For retatrutide, there is no FDA label yet, but the Phase 3 trial protocols follow similar missed-dose logic
The weight-loss equivalency framework (what the trials show) The table below compares mean weight loss at week 72 from the phase 3 obesity trials
Avoids Serious Complications In patients with severe anaemia, intensive treatment with B12 may result in a sudden drop in potassium (hypokalaemia), which can cause muscle weakness or an irregular heartbeat
Early generic entrants may price products at higher margins initially, with costs declining as additional manufacturers receive Health Canada approval and enter the Canadian market
and tirzepatide (Mounjaro, Zepbound, which works as a dual GLP-1/GIP [glucose-dependent insulinotropic polypeptide] agonist)
These conclusions are based on a study involving 710 patients with Type 2 diabetes